Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAI
2551
DELISTED
CAI International, Inc.
CAI
| $316K | ﹤0.01% |
5,664
+3,776
| +200% | +$211K |
|
|
DMTK
2552
DELISTED
DermTech, Inc. Common Stock
DMTK
| $313K | ﹤0.01% |
9,766
+3,483
| +55% | +$122K |
|
|
KLRS
2553
Kalaris Therapeutics
KLRS
$96.8M
| $312K | ﹤0.01% |
541
+305
| +129% | +$141K |
|
|
FRG
2554
DELISTED
Franchise Group, Inc.
FRG
| $312K | ﹤0.01% |
8,830
+4,754
| +117% | +$166K |
|
|
VRAY
2555
DELISTED
ViewRay, Inc.
VRAY
| $312K | ﹤0.01% |
43,194
+23,580
| +120% | +$149K |
|
2556
Precision BioSciences
DTIL
$207M
| $311K | ﹤0.01% |
899
+310
| +53% | +$105K |
|
|
CNR
2557
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $311K | ﹤0.01% |
21,299
+9,805
| +85% | +$159K |
|
2558
Braskem
BAK
$913M
| $310K | ﹤0.01% |
14,200
| – | – |
|
2559
Origin Bancorp
OBK
$1.66B
| $309K | ﹤0.01% |
7,292
+4,413
| +153% | +$181K |
|
2560
Akebia Therapeutics
AKBA
$252M
| $308K | ﹤0.01% |
107,045
+29,730
| +38% | +$84.9K |
|
2561
MBIA
MBI
$260M
| $308K | ﹤0.01% |
23,957
+9,592
| +67% | +$111K |
|
|
ECOM
2562
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $308K | ﹤0.01% |
12,205
+5,697
| +88% | +$140K |
|
|
RADI
2563
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $306K | ﹤0.01% |
18,743
+12,684
| +209% | +$204K |
|
|
GDEN
2564
DELISTED
Golden Entertainment
GDEN
| $305K | ﹤0.01% |
6,225
+3,648
| +142% | +$170K |
|
|
BMTC
2565
DELISTED
Bryn Mawr Bank Corp
BMTC
| $305K | ﹤0.01% |
6,647
+3,945
| +146% | +$159K |
|
2566
OrthoPediatrics
KIDS
$595M
| $302K | ﹤0.01% |
4,622
+2,684
| +138% | +$174K |
|
2567
ImmunityBio
IBRX
$8.1B
| $301K | ﹤0.01% |
30,976
+18,555
| +149% | +$204K |
|
2568
Peoples Bancorp
PEBO
$1.47B
| $300K | ﹤0.01% |
9,520
+6,087
| +177% | +$184K |
|
2569
Comstock Resources
CRK
$3.94B
| $297K | ﹤0.01% |
28,707
+16,077
| +127% | +$109K |
|
2570
Playboy Inc
PLBY
$141M
| $296K | ﹤0.01% |
12,562
+10,823
| +622% | +$291K |
|
2571
Argan
AGX
$8.37B
| $293K | ﹤0.01% |
6,690
+3,291
| +97% | +$149K |
|
2572
Krystal Biotech
KRYS
$9.66B
| $293K | ﹤0.01% |
5,595
+2,816
| +101% | +$167K |
|
|
MNRL
2573
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $293K | ﹤0.01% |
15,280
+9,647
| +171% | +$185K |
|
2574
Sportsman's Warehouse
SPWH
$46M
| $292K | ﹤0.01% |
16,628
+8,644
| +108% | +$153K |
|
|
GOOD
2575
Gladstone Commercial Corp
GOOD
$627M
| $290K | ﹤0.01% |
13,756
+7,238
| +111% | +$162K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.